Aytu BioScience has entered into agreements with five European distributors to market its MiOXSYS System, an in vitro diagnostic platform for the assessment of oxidative stress in semen to help diagnose male infertility.
The distributors include Tani Medikal in Turkey, TECOmedical in Switzerland and Germany, Parallabs in the UK and France, THP Medical Products in Austria and Durviz S.L. in Spain.
The platform nabbed CE marking in January. — Anisa Jibrell